The molecular diagnostics landscape is ever evolving. Find out more about the rapid development and implementation of high-value molecular diagnostics.
Dr. Tim Triche, the co-director of the Center of Personalized Medicine at Children’s Hospital LA, believes that our understanding of cancer is still largely one-dimensional.
Successful integrated health systems see value in bringing precision medicine to their patient populations. Progress starts in the laboratory. Discover the latest pharmacogenetics facts and trends.
|Article||Practicing Pharmacogenomics at Scale||Population Profiling,Molecular Diagnostics|
|Whitepaper||Pharmacogenetics Improves Health System Performance||Population Profiling,Molecular Diagnostics|
|Video||Advancing Precision Medicine, Better Pediatric Care, and the Role of Next-Generation Sequencing||Molecular Diagnostics,Targeted Therapeutics|
|Article||Cancer: Still a Multidimensional Challenge||Molecular Diagnostics,Targeted Therapeutics|
|Article||Next-Generation Sequencing: Marking the Lead from Concept to Clinic||Molecular Diagnostics,Targeted Therapeutics|
|Blog||Capitol Hill Briefing Sheds Light on Advancements and Hurdles Surrounding Molecular Diagnostics||Molecular Diagnostics|
|Blog||Genetic Analysis Tools help Doctors Design a Life-Saving Clinical Trial for Child with End-Stage Brain Cancer||Molecular Diagnostics|
|Blog||Non-small Cell Lung Cancer Survivor Becomes High-Profile Advocate for ROS1 Testing||Molecular Diagnostics|
|Webinar||The Journey to Realizing the Promise of Precision Medicine||Molecular Diagnostics|
|Webinar||Endeavor to Leave no Patient Behind: NGS in Routine NSCLC Biomarker Testing||Molecular Diagnostics|